Radiopharmaceuticals for single-photon emission computed tomography brain imaging

This publication has 102 references indexed in Scilit:

• PET imaging of dopamine transporters in the human brain using [11C]-β-CPPIT, a cocaine derivative lacking the 2β-ester function
  Nuclear Medicine and Biology, 2002
• [11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites
  Synapse, 2001
• Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters
  Synapse, 1998
• In vitro and in vivo characterisation of nor-?-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Differential kinetics of [123I]?-CIT binding to dopamine and serotonin transporters
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• ?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
• Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer
  Nuclear Medicine and Biology, 1995
• Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide
  Journal of Medicinal Chemistry, 1988
• In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system
  Life Sciences, 1988